Market Overview:
The global cell counting system market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for cell counting systems in research institutes, hospitals, and clinical laboratories. In addition, the increasing use of cell counting systems in pharmaceutical and biotechnology companies is also contributing to the growth of this market. However, factors such as high cost of advanced cell counting systems are restraining the growth of this market.
Product Definition:
A cell counting system is a device used to count the number of cells in a sample. The importance of cell counting systems varies depending on the application, but some common reasons for needing to count cells include research, diagnostics, and quality control.
Spectrophotometers:
A spectrophotometer is an instrument used for measuring the light spectrum of a particular source. It's basically a device that separates light into various colors and measures their intensity. The most common forms of spectrophotometers are liquid-in-glass, solid-in-liquid, and gas in glass types. They are widely used in research & development activities as well as quality control departments to analyze chemical compounds or solutions for impurities or analyze food products such as protein content etc.
Flow Cytometers:
Flow cytometers are instruments that are used for measuring the number of cells in a given sample. It is an important tool used by researchers and scientists for analyzing biological fluids such as blood, urine, serum or plasma. The analysis is based on the principle that different types of molecules move within a fluid at different speeds. As a result, they can be identified and characterized using flow cytometry techniques.
Application Insights:
Research Institutes held the largest share of over 70.0% in 2017. The major research institutes include National Cancer Center, Japan; University of Texas, USA; and Memorial Hermann Health System, Houston, USA. These institutes conduct various cell-based studies to understand cancer biology which drives the demand for global cell counting system market at these institutions.
The hospitals segment is expected to exhibit a lucrative CAGR during the forecast period owing to an increase in stem cells transplantation procedures and rising awareness about advanced diagnostics technologies that help detect even minuscule abnormalities in tumor cells or healthy cells/tissue samples (1). For instance, cytometry plays a vital role in monitoring disease progression post-transplantation as it provides real-time data on cellular changes associated with tissue homeostasis & metastasis (2).
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in research activities and an increase in funding by government entities. The U.S.-based companies are focusing on developing new products with advanced technology for diagnosis of various diseases, which is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to increasing R&D activities and rising healthcare expenditure by governments as well as private sectors across countries such as China, India, Japan, South Korea & Australia. These factors are expected to boost demand for cell counting systems during the forecast period from 2018-2030 in this region.
Countries such as Germany have been investing heavily in automation and robotics technologies that can be used for cell culture applications; these investments have led them at par with North America when it comes time regarding technological advancements within cells culture devices industry (Burgess et al., 2016).
Growth Factors:
- Increasing demand for cell-based therapies and regenerative medicine
- Rising prevalence of chronic diseases that require repeated blood tests and monitoring
- Growing number of clinical trials and research studies that require cell counting
- Technological advancements in cell counting systems
- Increasing funding for life science research
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell Counting System Market Research Report
By Type
Spectrophotometers, Flow Cytometers, Hematology Analyzers, Cell Counters
By Application
Research Institutes, Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Other End Users
By Companies
Danaher, Thermo Fisher, Becton, Dickinson, Merck, Bio-Rad Laboratories, GE Healthcare, Perkinelmer, Biotek Instruments, Agilent Technologies, Tecan, Abbott Laboratories, Siemens Healthineers, Roche, Sysmex, Horiba
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
171
Number of Tables & Figures
120
Customization Available
Yes, the report can be customized as per your need.
Global Cell Counting System Market Report Segments:
The global Cell Counting System market is segmented on the basis of:
Types
Spectrophotometers, Flow Cytometers, Hematology Analyzers, Cell Counters
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Institutes, Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Other End Users
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Danaher
- Thermo Fisher
- Becton, Dickinson
- Merck
- Bio-Rad Laboratories
- GE Healthcare
- Perkinelmer
- Biotek Instruments
- Agilent Technologies
- Tecan
- Abbott Laboratories
- Siemens Healthineers
- Roche
- Sysmex
- Horiba
Highlights of The Cell Counting System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Spectrophotometers
- Flow Cytometers
- Hematology Analyzers
- Cell Counters
- By Application:
- Research Institutes
- Hospitals
- Clinical Laboratories
- Pharmaceutical and Biotechnology Companies
- Other End Users
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell Counting System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A cell counting system is a laboratory tool used to measure the number of cells in a sample.
Some of the major players in the cell counting system market are Danaher, Thermo Fisher, Becton, Dickinson, Merck, Bio-Rad Laboratories, GE Healthcare, Perkinelmer, Biotek Instruments, Agilent Technologies, Tecan, Abbott Laboratories, Siemens Healthineers, Roche, Sysmex, Horiba.
The cell counting system market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cell Counting System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cell Counting System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cell Counting System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cell Counting System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cell Counting System Market Size & Forecast, 2018-2028
4.5.1 Cell Counting System Market Size and Y-o-Y Growth
4.5.2 Cell Counting System Market Absolute $ Opportunity
Chapter 5 Global Cell Counting System Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cell Counting System Market Size Forecast by Type
5.2.1 Spectrophotometers
5.2.2 Flow Cytometers
5.2.3 Hematology Analyzers
5.2.4 Cell Counters
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cell Counting System Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cell Counting System Market Size Forecast by Applications
6.2.1 Research Institutes
6.2.2 Hospitals
6.2.3 Clinical Laboratories
6.2.4 Pharmaceutical and Biotechnology Companies
6.2.5 Other End Users
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cell Counting System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cell Counting System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cell Counting System Analysis and Forecast
9.1 Introduction
9.2 North America Cell Counting System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cell Counting System Market Size Forecast by Type
9.6.1 Spectrophotometers
9.6.2 Flow Cytometers
9.6.3 Hematology Analyzers
9.6.4 Cell Counters
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cell Counting System Market Size Forecast by Applications
9.10.1 Research Institutes
9.10.2 Hospitals
9.10.3 Clinical Laboratories
9.10.4 Pharmaceutical and Biotechnology Companies
9.10.5 Other End Users
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cell Counting System Analysis and Forecast
10.1 Introduction
10.2 Europe Cell Counting System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cell Counting System Market Size Forecast by Type
10.6.1 Spectrophotometers
10.6.2 Flow Cytometers
10.6.3 Hematology Analyzers
10.6.4 Cell Counters
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cell Counting System Market Size Forecast by Applications
10.10.1 Research Institutes
10.10.2 Hospitals
10.10.3 Clinical Laboratories
10.10.4 Pharmaceutical and Biotechnology Companies
10.10.5 Other End Users
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cell Counting System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cell Counting System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cell Counting System Market Size Forecast by Type
11.6.1 Spectrophotometers
11.6.2 Flow Cytometers
11.6.3 Hematology Analyzers
11.6.4 Cell Counters
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cell Counting System Market Size Forecast by Applications
11.10.1 Research Institutes
11.10.2 Hospitals
11.10.3 Clinical Laboratories
11.10.4 Pharmaceutical and Biotechnology Companies
11.10.5 Other End Users
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cell Counting System Analysis and Forecast
12.1 Introduction
12.2 Latin America Cell Counting System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cell Counting System Market Size Forecast by Type
12.6.1 Spectrophotometers
12.6.2 Flow Cytometers
12.6.3 Hematology Analyzers
12.6.4 Cell Counters
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cell Counting System Market Size Forecast by Applications
12.10.1 Research Institutes
12.10.2 Hospitals
12.10.3 Clinical Laboratories
12.10.4 Pharmaceutical and Biotechnology Companies
12.10.5 Other End Users
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cell Counting System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cell Counting System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cell Counting System Market Size Forecast by Type
13.6.1 Spectrophotometers
13.6.2 Flow Cytometers
13.6.3 Hematology Analyzers
13.6.4 Cell Counters
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cell Counting System Market Size Forecast by Applications
13.10.1 Research Institutes
13.10.2 Hospitals
13.10.3 Clinical Laboratories
13.10.4 Pharmaceutical and Biotechnology Companies
13.10.5 Other End Users
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cell Counting System Market: Competitive Dashboard
14.2 Global Cell Counting System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Danaher
14.3.2 Thermo Fisher
14.3.3 Becton, Dickinson
14.3.4 Merck
14.3.5 Bio-Rad Laboratories
14.3.6 GE Healthcare
14.3.7 Perkinelmer
14.3.8 Biotek Instruments
14.3.9 Agilent Technologies
14.3.10 Tecan
14.3.11 Abbott Laboratories
14.3.12 Siemens Healthineers
14.3.13 Roche
14.3.14 Sysmex
14.3.15 Horiba
